CVS Health Corporation (NYSE:CVS) Given Consensus Rating of “Moderate Buy” by Analysts

CVS Health Corporation (NYSE:CVS) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three research firms that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $94.9091.

A number of equities research analysts have recently commented on CVS shares. The Goldman Sachs Group raised their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Robert W. Baird raised their price objective on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. TD Cowen upped their target price on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Finally, JPMorgan Chase & Co. raised their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th.

CVS Health Stock Down 0.9%

Shares of NYSE:CVS opened at $76.64 on Monday. The company has a 50 day moving average price of $78.52 and a two-hundred day moving average price of $76.87. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The company has a market capitalization of $97.50 billion, a PE ratio of 55.53, a PEG ratio of 0.80 and a beta of 0.50. CVS Health has a 52 week low of $58.35 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period last year, the firm posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts forecast that CVS Health will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. National Pension Service increased its stake in CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after acquiring an additional 119,189 shares during the last quarter. AE Wealth Management LLC lifted its stake in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after purchasing an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of CVS Health by 11.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after purchasing an additional 22,653 shares in the last quarter. Alpha Omega Wealth Management LLC increased its position in shares of CVS Health by 12.3% during the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after purchasing an additional 16,418 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in shares of CVS Health by 186.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock valued at $30,568,000 after buying an additional 258,050 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.